Actualités

Navitas Semiconductor (NASDAQ:NVTS) shares fell 7% on Wednesday morning after Wolfspeed (NYSE:WOLF) filed a patent infringement lawsuit against the company in the U. S.

PARIS, July 8 (Reuters) - France's competition authority on Wednesday ordered Meta Platforms to resume talks with French media groups over payments for publishing content, after the publishers

Amgen (AMGN) has moved into focus after initiating voluntary nationwide recalls of certain Corlanor and Sensipar tablet lots due to foreign substances and CGMP deviations, prompting investors to reassess drug quality and compliance risks. See our latest analysis for Amgen. Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...

Market Domination Host Josh Lipton tracks several of the day's top trending stock tickers, including JPMorgan analysts raising their price target on Eli Lilly (LLY) stock, Vertex Pharmaceuticals' (VRTX) acquisition of Crinetics (CRNX), and the possible $1.4 trillion lawsuit that multiple states are now suing Meta Platforms (META) for.

Amgen has initiated several product recalls in the US for Sensipar (cinacalcet) and Corlanor (ivabradine). The recalls involve multiple lots, dosage strengths, and large product quantities distributed nationwide. Regulators cited current good manufacturing practice (CGMP) deviations and contamination concerns affecting certain products. The pattern of recurring recalls extends beyond a single isolated lot or event. For investors following Amgen, ticker NasdaqGS:AMGN, the scale and...

On June 1, Michael Saylor-led Strategy (Nasdaq: MSTR), formerly MicroStrategy, announced that it sold 32 Bitcoin (BTC) for roughly $2.5 million between May 26 and May 31. It was the leading Bitcoin treasury company's first sale since 2022 and sparked a lot of volatility in ...

The recalls cover Mustang wiper issues and Mustang Mach-E drivetrain parts.

(Bloomberg) -- China’s securities regulator said it was monitoring developments in a US lawsuit after Susquehanna International Group alleged insider traders made at least $100 million from well-timed options bets before Beijing’s recent crackdown on illegal cross-border trading. Most Read from BloombergGreece Offers Bounty to Catch Ravenous Fish Lured by Warming SeaMicrosoft’s Xbox to Cut 3,200 Jobs, Divest Five Studios in Major OverhaulTwo Millennium Trading Pods Made About $3.7 Billion Last M

Four US states seek $1.4 trillion from Meta over teen addiction claims. See why Meta stock barely moved on the news.

The Paramount Skydance deal faces more regulatory attention.

Pfizer's IBRANCE has received new FDA approval as the first CDK4/6 inhibitor maintenance therapy for HR+, HER2+ metastatic breast cancer after induction treatment. The approval covers use of IBRANCE in combination with trastuzumab and endocrine therapy for patients with this subtype of breast cancer. The decision is based on results from the Phase 3 PATINA trial. For investors watching Pfizer (NYSE:PFE), this approval adds a fresh clinical milestone to a stock that has faced pressure in...

Ford ranked No. 1 among mass-market brands in J.D. Power's initial quality study.

European Court of Justice upholds a €4.1b antitrust fine against Alphabet on its Android practices. Ruling is final and concludes a multi year legal dispute over Android market dominance in Europe. Decision increases regulatory pressure on Alphabet's core search and mobile ecosystems globally. For investors tracking Alphabet, ticker NasdaqGS:GOOGL, this ruling directly touches the foundations of its Android, search, and app distribution businesses. Alphabet runs one of the most widely used...

NuScale Power (NYSE:SMR) is facing a legal challenge over claims it misrepresented the project experience of commercialization partner ENTRA1 in investor communications. The dispute raises questions about disclosure practices and potential legal and reputational consequences for future NuScale projects. Separately, NuScale awarded Paragon an engineering contract to design the highly integrated protection system for its certified small modular reactor modules. NuScale is currently the only...

Snap stock is caught between a harsh trading history and a more forgiving valuation read, with shares down sharply over several years even as some market multiples now point to potential undervaluation. Snap has declined about 92.6% over the past 5 years, which shows how severely long term holders have been hit despite occasional short term bounces. Recent product updates such as AI powered advertising tools and smart glasses can support growth expectations, while legal and regulatory...

A major lawsuit has been filed against Snap Inc. alleging that Snapchat's design and recommendation systems enabled grooming and abuse of minors. The case follows renewed scrutiny after a dark web manual surfaced that explicitly targets Snapchat features for child exploitation. The allegations focus on user safety, product design choices, and how Snapchat's algorithms connect users on the platform. The filing raises new questions about Snap's regulatory risk and potential exposure to tighter...

Halper Sadeh LLC has initiated a legal investigation into e.l.f. Beauty (NYSE:ELF). The investigation focuses on whether certain officers and directors breached fiduciary duties to shareholders. Potential outcomes include corporate governance reforms or financial restitution for investors. The probe is ongoing and centers on board oversight and accountability to shareholders. e.l.f. Beauty operates in the cosmetics and skincare space, a segment where brand strength, consumer trust, and...

FDA approved expanded use of CASGEVY for children as young as two years with sickle cell disease and transfusion-dependent beta thalassemia. The approval makes CASGEVY the first gene therapy of its kind available to this pediatric group in the U.S. Vertex Pharmaceuticals estimates that roughly 5,500 additional children in the U.S. may now be eligible for this one-time genetic treatment. Vertex Pharmaceuticals, traded as NasdaqGS:VRTX, now has FDA approval to offer CASGEVY to a much younger...

ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.

The complaint focuses on Nike’s “Air Max 95 Big Bubble” trainer in a “sport green and safety orange” colourway.

7-Eleven has filed a trademark lawsuit against NIKE over the design of an upcoming Air Max 95 sneaker. The dispute centers on alleged use of 7-Eleven's branding elements in the shoe's color scheme and design. The case introduces legal risk around a product launch that targets collectors and sneaker-focused consumers. NIKE, traded as NYSE:NKE, is dealing with this legal challenge at a time when the stock has fallen 30.3% year to date and 40.7% over the past year, with the current share price...

The judgment concludes a legal dispute that began after the European Commission fined Google in 2018 for abusing market dominance.

Futu Holdings is facing multiple securities class action lawsuits in the U.S. after Chinese regulators accused the company of running unlicensed securities, public fund sales, and futures businesses in mainland China and proposed penalties totaling about RMB 1.85 billion (around US$271 million), which Futu has already reflected in its reported earnings. The lawsuits allege that Futu overstated its financial results and misled investors about regulatory compliance, putting the company’s...

Pomerantz LLP has opened an investor investigation into ON Semiconductor (NasdaqGS:ON) following the announced acquisition of Synaptics. The review focuses on potential securities law violations or unlawful business practices linked to the deal and the sharp share price drop that followed. This adds a legal dimension to the Synaptics transaction that may be relevant for current and prospective ON Semiconductor shareholders. ON Semiconductor operates in the semiconductor sector, supplying...

Alphabet Inc (NASDAQ:GOOG) shares traded about 1% lower on Thursday after the European Court of Justice (ECJ) upheld a €4.1 billion ($4.67 billion) antitrust fine against Google over its Android mobile operating system. The ruling marks the end of Google's legal challenge against the European...

EU court backs regulators in long-running case.

Europe's top court upheld findings that Google abused Android's market dominance.

On this episode of Stock Movers: - SoftBank (SFTBY) shares are responding to news that it is starting a new U.S. venture to rent out the computing power needed to build and run artificial-intelligence models, aiming to capitalize on strong American demand for AI computing resources. - Shares of Alphabet/Google (GOOG) are responding to the company losing its long-running fight against a 4.1 billion ($4.7 billion) European Union antitrust fine after the bloc's top judges said regulators were right to punish the US giant for abusing Android's market power.

Judges at the European Union's top court dismissed an appeal by Google over a landmark, 4.1 billion euro ($4.5 billion) antitrust fine imposed for throttling competition and reducing consumer choice through the dominance of its mobile Android operating system. The case has been tangled up in courts since the European Commission announced the fine in 2018. “The appeal brought by Google and its parent company Alphabet against the judgment of the General Court is dismissed, thereby confirming the penalty imposed for Google Search’s abuse of a dominant position in the context of the Android operating system,” the Luxembourg-based judges wrote in their ruling.

Alphabet's Google on Thursday lost its fight against a record fine imposed by ‌EU antitrust regulators eight years ago for using its Android mobile operating ‌system to block rivals, a court ruling likely to boost Europe's crackdown on Big Tech. The European ​Commission had originally handed out a €4.34 billion fine to Google in 2018 for its agreements which forced phone manufacturers to pre-install Google Search, the Chrome browser and the Google Play app store on their Android devices and prevented them from using rival ‌Android systems. Google then appealed ⁠to the Luxembourg-based Court of Justice of the European Union, Europe's highest.